elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36639084-71BD60A7-B42B-4694-A162-1D503B46B265
Q36639084-71BD60A7-B42B-4694-A162-1D503B46B265
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36639084-71BD60A7-B42B-4694-A162-1D503B46B265
Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
P2860
Q36639084-71BD60A7-B42B-4694-A162-1D503B46B265
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36639084-71BD60A7-B42B-4694-A162-1D503B46B265
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3be557b5ed6b1f7295c5f05afd316a12729c2801
P2860
Global spending on orphan drugs in France, Germany, the UK, Italy and Spain during 2007.